HUTCHISON CHINA MED. Chart calendar HUTCHISON CHINA MED.
5aa9e9554030c9e9cda56.dFmvw1Qy05ZBwdWwLOZ3-AkH3Jt3OVml6yhZg5XjsgM.PAjWtmV35cAY7KbBVrBBsktO6eIWZjzqxmkwtvSWg2kWEcqTLnzn4yj35Q~c6321fce9529b7c61286da1911dcc277
Upcoming events on HUTCHISON CHINA MED.
Past events on HUTCHISON CHINA MED.
| 2024-06-16 06:00 | European Hematology Association Meeting - Abstract : #S297 |
| 2024-06-14 09:00 | European Hematology Association Meeting - Abstract : #S316 |
| 2024-06-13 | European Hematology Association Meeting - Abstract::#P532 |
| 2024-06-13 | European Hematology Association Meeting - Abstract::#P2054 |
| 2024-06-13 | European Hematology Association Meeting - Abstract::#P2080 |
| 2024-06-13 | European Hematology Association Meeting - Abstract::#P549 |
| 2024-06-13 | European Hematology Association Meeting - Abstract::#P1102 |
| 2024-06-13 | European Hematology Association Meeting - Abstract:: #P1631 |
| 2024-06-13 | European Hematology Association Meeting - Abstract : #P1629 |
| 2024-05-30 | American Society of Clinical Oncology Meeting |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e15127 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e16047 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e16375 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e15124 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e15123 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #11539 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e15570 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e15112 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : #e15109 |
| 2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No : 438730 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 205 197 3.87% | 228 219 4.02% | 356 339 5.12% | 426 410 4.06% | 838 800 4.81% | 691 |
|
EBITDA Million USD | Released Forecast Spread | -141 -138 -2.61% | -191 -171 -11.34% | -321 -315 -2.02% | -399 -386 -3.38% | 26,6 -31,8 183.56% | -144 |
|
EBIT Million USD | Released Forecast Spread | -146 -143 -2.67% | -197 -180 -9.04% | -328 -322 -2.04% | -408 -394 -3.44% | 18,4 -41,1 144.67% | -159 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -141 -152 6.98% | -190 -190 0.11% | -216 -297 27.35% | -410 -380 -7.98% | 58,3 -6,88 947.71% | -131 |
|
Net income Million USD | Released Forecast Spread | -106 -121 12.33% | -126 -130 3.43% | -195 -256 23.84% | -361 -368 1.82% | 101 12,3 716.24% | -106 |
|
EPS USD | Released Forecast Spread | -0,16 -0,18 11.72% | -0,18 -0,20 11.33% | -0,25 -0,35 29.19% | -0,43 -0,44 2.37% | 0,12 0,01 1076.47% | -0,13 |
| Announcement Date | 03/03/20 | 04/03/21 | 03/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 103 120 -14.11% | 107 94,1 13.51% | 121 109 10.92% | 157 136 15.49% | 199 180 10.35% | 202 175 15.31% | 224 210 6.82% | 533 308 73.05% | 305 301 1.39% | 322 | 349 | 405 | 415 |
|
EBIT Million USD | Released Forecast Spread | -78,2 -84,6 7.61% | -119 -134 11.3% | -144 -161 10.73% | -185 -185 0.35% | -197 -199 1.11% | -211 -222 5.19% | 112 -115 197.22% | -93,3 -138 32.46% | -65,2 | -79,6 | -61,4 | -67,5 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -76,6 -84,8 9.69% | -113 -132 14.54% | -140 -179 21.36% | -75,3 -177 57.57% | -201 -200 -0.22% | -210 -240 12.44% | -78,8 -203 61.19% | -39,7 | -103 | ||||
|
Net income Million USD | Released Forecast Spread | -49,7 -60,7 18.13% | -76,0 -86,7 12.3% | -102 -153 32.99% | -92,3 -127 27.42% | -163 -186 12.2% | -198 -232 14.56% | -67,8 -182 62.8% | -52,6 | -64,3 | ||||
| Announcement Date | 03/03/20 | 30/07/20 | 04/03/21 | 28/07/21 | 03/03/22 | 01/08/22 | 28/02/23 | 31/07/23 | 28/02/24 | - | - | - | - |
More events
Past sector events for HUTCHISON CHINA MED.
| Today | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 2024-06-21 11:28 | DEVA HOLDING: Q1 2024 Earnings Release |
| 2024-06-13 17:21 | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 2024-06-11 01:30 | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 2024-06-07 06:33 | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 2024-06-07 05:17 | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 2024-05-30 08:08 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-30 07:00 | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 2024-05-30 02:24 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-29 08:00 | FDC LIMITED: Q4 2024 Earnings Release |
